Home/Filings/4/0001127602-13-012015
4//SEC Filing

DODION PIERRE F 4

Accession 0001127602-13-012015

CIK 0000884731other

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 4:38 PM ET

Size

8.3 KB

Accession

0001127602-13-012015

Insider Transaction Report

Form 4
Period: 2013-03-22
DODION PIERRE F
Senior VP, Chief Medical Off
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2013-03-2220,3330 total
    Common Stock (20,333 underlying)
  • Exercise/Conversion

    Common Stock

    2013-03-22+20,33362,215 total
  • Sale

    Common Stock

    2013-03-25$18.87/sh8,133$153,48254,082 total
Footnotes (4)
  • [F1]Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
  • [F2]Represents shares withheld to satisfy withholding tax requirements.
  • [F3]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
  • [F4]The restricted stock units vested on March 20, 2013.

Issuer

ARIAD PHARMACEUTICALS INC

CIK 0000884731

Entity typeother

Related Parties

1
  • filerCIK 0001403174

Filing Metadata

Form type
4
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 4:38 PM ET
Size
8.3 KB